Mevaseret Zion, Israel

Nissim Ben-Arie



Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nissim Ben-Arie: Innovator in Therapeutic Compositions

Introduction

Nissim Ben-Arie is a notable inventor based in Illinois. He has made significant contributions to the field of therapeutic compositions, particularly in relation to deafness, osteoarthritis, and abnormal cell proliferation. His work focuses on the use of atonal-associated sequences for therapeutic applications.

Latest Patents

Nissim Ben-Arie holds a patent titled "Compositions For The Therapeutic Use Of An Atonal-Associated Sequence For Deafness, Osteoarthritis, And Abnormal Cell Proliferation." This patent discloses compositions and methods for the therapeutic use of an atonal-associated nucleic acid or amino acid sequence. The invention also includes an animal model heterozygous for an atonal-associated gene inactivation, which has at least one atonal-associated nucleic acid sequence replaced by the insertion of a heterologous nucleic acid sequence. This model is used to detect expression driven by an atonal-associated promoter sequence, wherein the inactivation of the atonal-associated nucleic acid sequence prevents its expression.

Career Highlights

Nissim Ben-Arie is affiliated with the Baylor College of Medicine, where he conducts his research and development work. His innovative approaches have the potential to impact various medical conditions significantly.

Collaborations

Nissim has collaborated with esteemed colleagues such as Huda Y Zoghbi and Hugo Bellen. These collaborations enhance the depth and breadth of his research efforts.

Conclusion

Nissim Ben-Arie's work in therapeutic compositions showcases his dedication to advancing medical science. His innovative contributions are paving the way for new treatments in critical health areas.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…